EDGAR Filing Documents for 0001104659-22-030112

Form 8-K - Current report:

SEC Accession No. 0001104659-22-030112

Filing Date

2022-03-03

Accepted

2022-03-03 17:21:13

Documents

Period of Report

2022-03-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm227839d3_8k.htm iXBRL	8-K	35741
2	EXHIBIT 1.1	tm227839d3_ex1-1.htm	EX-1.1	247778
3	EXHIBIT 3.1	tm227839d3_ex3-1.htm	EX-3.1	88987
4	EXHIBIT 5.1	tm227839d3_ex5-1.htm	EX-5.1	9477
5	EXHIBIT 99.1	tm227839d3_ex99-1.htm	EX-99.1	10114
6	GRAPHIC	tm227839d3_ex5-1img001.jpg	GRAPHIC	2752
7	GRAPHIC	tm227839d3_ex99-1img001.jpg	GRAPHIC	5068
	Complete submission text file	0001104659-22-030112.txt		671901

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	hook-20220301.xsd	EX-101.SCH	3048
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	hook-20220301_lab.xml	EX-101.LAB	34476
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	hook-20220301_pre.xml	EX-101.PRE	22605
12	EXTRACTED XBRL INSTANCE DOCUMENT	tm227839d3_8k_htm.xml	XML	3818

Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016

Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360

HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)